SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-08-007614
Filing Date
2008-09-24
Accepted
2008-09-24 17:32:58
Documents
21
Period of Report
2008-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIGAND PHARMACEUTICALS INC. 8-K a5787560.htm 8-K 28346
2 EXHIBIT 99.1 a5787560ex99_1.htm EX-99.1 23329
3 EXHIBIT 99.2 a5787560ex99_2.htm EX-99.2 20942
4 SLIDE 1 slide1.jpg GRAPHIC 47581
5 SLIDE 2 slide2.jpg GRAPHIC 154697
6 SLIDE 3 slide3.jpg GRAPHIC 186168
7 SLIDE 4 slide4.jpg GRAPHIC 36101
8 SLIDE 5 slide5.jpg GRAPHIC 100464
9 SLIDE 6 slide6.jpg GRAPHIC 68551
10 SLIDE 7 slide7.jpg GRAPHIC 112655
11 SLIDE 8 slide8.jpg GRAPHIC 71058
12 SLIDE 9 slide9.jpg GRAPHIC 81715
13 SLIDE 10 slide10.jpg GRAPHIC 90267
14 SLIDE 11 slide11.jpg GRAPHIC 66399
15 SLIDE 12 slide12.jpg GRAPHIC 90141
16 SLIDE 13 slide13.jpg GRAPHIC 50322
17 SLIDE 14 slide14.jpg GRAPHIC 92101
18 SLIDE 15 slide15.jpg GRAPHIC 74770
19 SLIDE 16 slide16.jpg GRAPHIC 75555
20 SLIDE 17 slide17.jpg GRAPHIC 57726
21 SLIDE 18 slide18.jpg GRAPHIC 71752
  Complete submission text file 0001157523-08-007614.txt   2181936
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 081087246
SIC: 2834 Pharmaceutical Preparations